Atazanavir and Leuprolide and norethindrone Intramuscular, Oral
Determining the interaction of Atazanavir and Leuprolide and norethindrone Intramuscular, Oral and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Ask your doctor before using norethindrone together with atazanavir. Atazanavir may affect the safety and decrease the birth control effectiveness of norethindrone. Women who use birth control pills or birth control patches should choose a different kind of contraception during atazanavir therapy. Using norethindrone together with atazanavir can also increase the blood levels or add to the side effects of norethindrone. This can cause sudden headache, confusion, pain behind the eyes, problems with vision, speech, or balance, nausea, and stomach pain. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Coadministration with atazanavir may increase the plasma concentrations of ethinyl estradiol and norethindrone and possibly other contraceptive hormones. The mechanism is atazanavir inhibition of CYP450 3A4 and UGT1A1, the enzymes responsible for the metabolic clearance of contraceptive hormones. In 19 study subjects, atazanavir (400 mg once a day for 14 days) increased the mean steady-state peak plasma concentration (Cmax), area under the concentration-time curve (AUC) and trough plasma concentration (Cmin) of ethinyl estradiol (Ortho-Novum 7/7/7) by 15%, 48% and 91%, respectively, compared to administration of the oral contraceptive alone. The Cmax, AUC and Cmin of norethindrone were increased by 67%, 110% and 262%, respectively. Decreased HDL or increased insulin resistance may be associated with elevated plasma concentrations of norethindrone.
MANAGEMENT: The manufacturer recommends alternate methods of nonhormonal contraception during atazanavir or atazanavir-ritonavir therapy.
- "Product Information. Reyataz (atazanavir)." Bristol-Myers Squibb, Princeton, NJ.
Generic Name: leuprolide / norethindrone
Brand name: Lupaneta Pack
Synonyms: Leuprolide and norethindrone, Leuprolide and Norethindrone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atazanavir-Leuprolide Injection (CPP)
- Atazanavir-Leuprolide Injection (Prostate)
- Atazanavir-Leuprolide Injection (Women)
- Atazanavir-Leuprolide Intramuscular, Subcutaneous, Intradermal, Injection
- Atazanavir-Leustatin
- Atazanavir-Leustatin injection
- Leuprolide and norethindrone Intramuscular, Oral-Atazanavir and cobicistat
- Leuprolide and norethindrone Intramuscular, Oral-Atazanavir Capsules
- Leuprolide and norethindrone Intramuscular, Oral-Atazanavir Powder for Oral Suspension
- Leuprolide and norethindrone Intramuscular, Oral-Atazanavir Sulfate
- Leuprolide and norethindrone Intramuscular, Oral-Atelvia
- Leuprolide and norethindrone Intramuscular, Oral-Atendia Patch